Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in VERU — Veru Inc.

CIK 73124 CHICAGO, IL
Back to VERU Full portfolio

Position in VERU

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$93,446
+$19,217 QoQ
Shares Held
29,855
-11.1% QoQ
Ownership
0.175%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 61 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. VERU ranks #356 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in VERU

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $93,446 29,855
2026-03-31 $74,229 33,588
2025-12-31 $71,878 33,588
2025-09-30 $97,112 25,556
2025-06-30 $148,232 255,574
2025-03-31 $513,399 1,047,756
2024-12-31 $668,962 1,029,174
2024-09-30 $814,585 1,057,904
2024-06-30 $257,940 307,072
2024-03-31 $184,711 263,874
2023-12-31 $106,228 147,539
2023-09-30 $84,216 116,968
2023-06-30 $112,025 94,139
2023-03-31 $652,030 562,096
2022-12-31 $2,944,422 557,656
2022-09-30 $6,447,766 559,702
2022-06-30 $6,571,965 581,590
2022-03-31 $2,838,469 587,675
2021-12-31 $3,609,856 612,879
2021-09-30 $5,280,836 619,090
2021-06-30 $5,185,642 642,583
2021-03-31 $6,241,736 579,011
2020-12-31 $5,145,105 594,810
2020-09-30 $1,526,303 582,559
2020-06-30 $692,050 207,201
2020-03-31 $334,651 102,340